ProtoKinetix (PKTX) Stock Price, News & Analysis

Company Overview

ProtoKinetix, Inc. is a biotechnology company focused on developing therapeutic products and technologies for regenerative medicine and cell preservation. The company’s research is centered on proprietary synthetic glycopeptides intended to help protect cells from stress and improve cell survival.

ProtoKinetix’s principal product candidate is PKX-001, an engineered glycopeptide being evaluated for potential applications in areas such as cell and tissue preservation, regenerative medicine, and the support of cellular therapies. The company has also explored potential uses involving stem cells and other biological materials.

ProtoKinetix is publicly traded in the United States under the symbol PKTX. Publicly available information about its current leadership, commercial operations, and geographic reach is limited, and the company’s programs remain primarily focused on research and development.

Key Stats

• Today's Range: $0.0002 to $0.0002
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0124
• Volume: N/A
• Average Volume: 144,983 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:PKTX
• Previous Symbol: NASDAQ:PKTX
• CIK: 1128189
• Web: www.protokinetix.com
• Phone: (330) 445-4971
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A